Table 4.
Infection site/organism | Improved, n | Failed, n | Indeterminate, n |
---|---|---|---|
All sites, total | 25 | 16 | 11 |
M. abscessus complex | 18 | 12 | 8 |
M. chelonae | 5 | 3 | 1 |
M. abscessus complex/ M. chelonae | 2 | 1 | 2 |
Lung, total | 16 | 11 | 9 |
M. abscessus complex | 13 | 9 | 8 |
M. chelonae | 1 | 1 | 0 |
M. abscessus complex/ M. chelonae | 2 | 1 | 1 |
Extrapulmonary, total | 9 | 5 | 2 |
skin/soft tissue | |||
M. abscessus complex | 2 | 0 | 0 |
M. chelonae | 3 | 1 | 1 |
bone | |||
M. abscessus complex | 1 | 0 | 0 |
multiple | |||
M. abscessus complex | 0 | 1 | 0 |
M. chelonae | 1 | 1 | 0 |
blood | |||
M. abscessus complex | 1 | 0 | 0 |
M. abscessus complex/ M. chelonae | 0 | 0 | 1 |
CNS | |||
M. abscessus complex | 0 | 1 | 0 |
prosthesis | |||
M. abscessus complex | 0 | 1 | 0 |
prophylaxis | |||
M. abscessus complex | 1 | 0 | 0 |
aPatients in this table were not separated into treatment groups of <1 or ≥1 month as in Table 3.